Larimar Therapeutics

Youtube Subscribe

Open: 11.96 Close: 13.28 Change: 1.32

How to get information about Larimar Therapeutics Company Inc Stock without reading the whole internet.

This document will help you to evaluate Larimar Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Larimar Therapeutics are: Larimar, Therapeutics, Inc, LRMR, risen, last, earnings, …

Concept Map

Semantic Network

Stock Summary

Larimar Therapeutics, Inc. focuses on developing treatments for rare diseases. Its lead product candidate is CTI-1601, which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia..

Today's Summary

Larimar Therapeutics Inc (LRMR) stock is lower by -7.6% while the S&P 500 has risen 0.01% as of 10:15 AM on Monday, Feb 12. Larimar uses net proceeds to support the development of nomlabofusp (CTI-1601) and other pipeline candidates.

Today's News

Larimar Therapeutics, Inc. Announces Pricing of Underwritten Public Offering of Common Stock Rhea-AI Impact (Low) Rhea Sentiment (Neutral) Tags offering. Larimar uses net proceeds to support the development of nomlabofusp (CTI-1601) and other pipeline candidates. Larimar Therapeutics Inc (LRMR) stock is lower by -7.6% while the S&P 500 has risen 0.01% as of 10:15 AM on Monday, Feb 12. Buy rating affirmed on larimar therapeutics amid promising clinical trial results and accelerated approval pathway. Larimar Therapeutics ( NASDAQ:LRMR – Get Free Report ) last announced its quarterly earnings data on Tuesday, November 14th. The businesss fifty day simple moving average is $5.02 and its 200 day moving average of $4.07. Larimar Therapeutics Inc. hiring manager/sr. manager of analytical sciences in bala-cynwyd, pennsylvania, united states | linkedin.in. PI236653671. Shares of Larimar Therapeutics opened at $11.96 on Thursday. Shares of LRMR opened at. $2.18 and a 1 year high of $12.92. Larimar Therapeutics Inc has risen 89.59% over the past month, closing at $4.21 on January 17. The company is set to release earnings on 2024-03-12. Over the last 12 months, the company has reported EPS of $-0.60.

Stock Profile

"Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is headquartered in Bala Cynwyd, Pennsylvania."

Keywords

The game is changing. There is a new strategy to evaluate Larimar Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Larimar Therapeutics are: Larimar, Therapeutics, Inc, LRMR, risen, last, earnings, and the most common words in the summary are: larimar, stock, therapeutic, news, best, share, inc, . One of the sentences in the summary was: Larimar Therapeutics Inc (LRMR) stock is lower by -7.6% while the S&P 500 has risen 0.01% as of 10:15 AM on Monday, Feb 12. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #larimar #stock #therapeutic #news #best #share #inc.

Read more →

Youtube Subscribe

---